Work

Turning cold into hot: combination of pembrolizumab with bevacizumab and oral metronomic cyclophosphamide increases immune cell migration into the tumor microenvironment in responding patients with recurrent ovarian cancer (090)

Year: 2022

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/s0090-8258(22)01316-6

Authors: Nicole Gaulin, Shanmuga Reddy Chilakapati, Emese Zsiros

Institution: Roswell Park Comprehensive Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4295226752

FWCI: 0.516

Cites:

Cited by: 3

Related to: 10